Maryanne Caruana,Marieke J Baars,Evy Bashiardes,Kalman Benke,Erik Björck,Andrei Codreanu,Elena de Moya Rubio,Julia Dumfarth,Arturo Evangelista,Maarten Groenink,Klaus Kallenbach,Marlies Kempers,Anna Keravnou,Bart Loeys,Laura Muiño-Mosquera,Edit Nagy,Olivier Milleron,Stefano Nistri,Guglielmina Pepe,Jolien Roos-Hesselink,Zoltan Szabolcs,Gisela Teixidó-Tura,Janneke Timmermans,Ingrid Van de Laar,Roland van Kimmenade,Aline Verstraeten,Yskert Von Kodolitsch,Julie De Backer,Guillaume Jondeau

Abstract:Heritable thoracic aortic diseases (HTAD) are rare pathologies associated with thoracic aortic aneurysms and dissection, which can be syndromic or non-syndromic. They may result from genetic defects. Associated genes identified to date are classified into those encoding components of the (a) extracellular matrix (b) TGFβ pathway and (c) smooth muscle contractile mechanism. Timely diagnosis allows for prompt aortic surveillance and prophylactic surgery, hence improving life expectancy and reducing maternal complications as well as providing reassurance to family members when a diagnosis is ruled out. This document is an expert opinion reflecting strategies put forward by medical experts and patient representatives involved in the HTAD Rare Disease Working Group of VASCERN. It aims to provide a patient pathway that improves patient care by diminishing time to diagnosis, facilitating the establishment of a correct diagnosis using molecular genetics when possible, excluding the diagnosis in unaffected persons through appropriate family screening and avoiding overuse of resources. It is being recommended that patients are referred to an expert centre for further evaluation if they meet at least one of the following criteria: (1) thoracic aortic dissection (<70 years if hypertensive; all ages if non-hypertensive), (2) thoracic aortic aneurysm (all adults with Z score >3.5 or 2.5-3.5 if non-hypertensive or hypertensive and <60 years; all children with Z score >3), (3) family history of HTAD with/without a pathogenic variant in a gene linked to HTAD, (4) ectopia lentis without other obvious explanation and (5) a systemic score of >5 in adults and >3 in children. Aortic imaging primarily relies on transthoracic echocardiography with magnetic resonance imaging or computed tomography as needed. Genetic testing should be considered in those with a high suspicion of underlying genetic aortopathy. Though panels vary among centers, for patients with thoracic aortic aneurysm or dissection or systemic features these should include genes with a definitive or strong association to HTAD. Genetic cascade screening and serial aortic imaging should be considered for family screening and follow-up. In conclusion, the implementation of these strategies should help standardise the diagnostic work-up and follow-up of patients with suspected HTAD and the screening of their relatives.

EACTS/STS Guidelines for Diagnosing and Treating Acute and Chronic Syndromes of the Aortic Organ

Acute Aortic Syndromes from Diagnosis to Treatment—A Comprehensive Review

Current knowledge and contemporary management of non-A non-B aortic dissections

European registry of type A aortic dissection (ERTAAD) - rationale, design and definition criteria

Aortic Outcome after Implementation of a Treatment Strategy for Type B Aortic Dissection Involving the Aortic Arch

Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms

An Evolving Research Field with Custom-Made Solutions

Acute type A aortic dissection – a review

Classification of the Urgency of the Procedure and Outcome of Acute Type A Aortic Dissection

ANMCO/SIC/SICI-GISE/SICCH Executive Summary of Consensus Document on Risk Stratification in elderly patients with aortic stenosis before surgery or transcatheter aortic valve replacement

Update in the Management of Aortic Dissection

Acute Aortic Dissection: Observational Lessons Learned From 11 000 Patients

The Aortic Team Model and Collaborative Decision Pathways for the Management of Complex Aortic Disease: Clinical Practice Update From the Canadian Cardiovascular Society/Canadian Society of Cardiac Surgeons/Canadian Society for Vascular Surgery/Canadian Association for Interventional Radiology

Management of acute aortic syndrome with evolving individualized precision medicine solutions: Lessons learned over two decades and literature review

Interdisciplinary Expert Consensus Document on Management of Type B Aortic Dissection

Clinical Analysis of 391 Cases of Acute Aortic Syndrome

Comprehensive assessment of the aortic valve in critically ill patients for the non-cardiologist. Part I: Aortic stenosis of the native valve

ESC/EACTS vs. ACC/AHA guidelines for the management of severe aortic stenosis

HTAD patient pathway: Strategy for diagnostic work-up of patients and families with (suspected) heritable thoracic aortic diseases (HTAD). A statement from the HTAD working group of VASCERN

Aortic elongation part II: the risk of acute type A aortic dissection

Insights From the Histopathologic Analysis of Acquired and Genetic Thoracic Aortic Aneurysms and Dissections